Muye Zhou
Impact in
-
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Lipid Membrane Structure and Behavior
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 3
- Lipid Membrane Structure and Behavior 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Bowen Li (5 shared papers)Yue Xu (4 shared papers)Alex Golubovic (4 shared papers)Rick Xing Ze Lu (3 shared papers)Shufen Xu (2 shared papers)Andrew Varley (2 shared papers)Fanglin Gong (4 shared papers)Jingan Chen (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Controlled Release (2 papers)Nature Communications (1 paper)Frontiers in Oncology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- CanadaChinaUnited States
In The Last Decade
Muye Zhou
9 papers receiving 285 citations
Muye Zhou's Hit Papers
Peers
Comparison fields: 5 of 56
- Molecular Biology 188
- Biomaterials 36
- Pharmaceutical Science 12
- Immunology 34
- Infectious Diseases 24
Countries citing papers authored by Muye Zhou
This map shows the geographic impact of Muye Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muye Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muye Zhou more than expected).
Fields of papers citing papers by Muye Zhou
This network shows the impact of papers produced by Muye Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muye Zhou. The network helps show where Muye Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Muye Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery Hit paper breakdown → | 2024 | 114 |
| 2 | 2023 | 95 | |
| 3 | 2023 | 21 | |
| 4 | 2025 | 21 | |
| 5 | 2022 | 19 | |
| 6 | 2018 | 12 | |
| 7 | 2023 | 4 | |
| 8 | 2025 | 1 | |
| 9 | Preparation and in vitro evaluation of artemisinin loaded long-circulating liposomes. | 2018 | 1 |
| 10 | 2025 | 0 | |
| 11 | 2024 | 0 |
About Muye Zhou
Muye Zhou is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Infectious Diseases and Immunology, having authored 11 papers that have together received 288 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Advanced biosensing and bioanalysis techniques (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Immunotherapy and Immune Responses (2 papers), Lipid Membrane Structure and Behavior (2 papers), Drug Solubulity and Delivery Systems (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Molecular Biology (188 citations), Biomaterials (36 citations), Pharmaceutical Science (12 citations), Immunology (34 citations) and Infectious Diseases (24 citations). Muye Zhou has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Bowen Li, Yue Xu, Alex Golubovic, Rick Xing Ze Lu, Shufen Xu, Andrew Varley, Fanglin Gong, Jingan Chen, Bo Wang and Haotian Cui. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Controlled Release, Nature Communications, Frontiers in Oncology and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.